{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prochymal%C2%AE", "query": { "intervention": "Prochymal®" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prochymal%C2%AE&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T03:04:08.464Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00543374", "title": "Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "PROCHYMAL adult human mesenchymal stem cells", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 98, "start_date": "2007-09-17", "completion_date": "2011-04-28", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 53, "location_summary": "Anaheim, California • Long Beach, California • Los Angeles, California + 44 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00543374" }, { "nct_id": "NCT01233960", "title": "Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Prochymal®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 73, "start_date": "2010-11-29", "completion_date": "2014-09-15", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 16, "location_summary": "San Francisco, California • Clearwater, Florida • Winter Park, Florida + 11 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Winter Park", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Topeka", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01233960" }, { "nct_id": "NCT00690066", "title": "PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 1 Diabetes Mellitus", "Type 1 Diabetes", "Diabetes Mellitus, Insulin-Dependent", "Juvenile Diabetes" ], "interventions": [ { "name": "PROCHYMAL®", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "12 Years to 35 Years" }, "enrollment_count": 63, "start_date": "2008-06-11", "completion_date": "2011-12-19", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 20, "location_summary": "Birmingham, Alabama • La Jolla, California • Stanford, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00690066" }, { "nct_id": "NCT00366145", "title": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Graft Versus Host Disease" ], "interventions": [ { "name": "Prochymal®", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of Care for GVHD", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "70 Years", "sex": "ALL", "summary": "6 Months to 70 Years" }, "enrollment_count": 260, "start_date": "2006-08-17", "completion_date": "2009-05-28", "has_results": false, "last_update_posted_date": "2022-02-10", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Duarte, California + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00366145" }, { "nct_id": "NCT01510431", "title": "Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease", "overall_status": "NO_LONGER_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "PROCHYMAL (remestemcel-L)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2020-03-10", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 4, "location_summary": "San Francisco, California • Topeka, Kansas • New York, New York + 1 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Topeka", "state": "Kansas" }, { "city": "New York", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01510431" }, { "nct_id": "NCT00759018", "title": "Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD", "overall_status": "NO_LONGER_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Graft vs Host Disease", "Graft-Versus-Host Disease" ], "interventions": [ { "name": "remestemcel-L", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "2 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Months to 17 Years" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2020-03-09", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 24, "location_summary": "Phoenix, Arizona • Orange, California • San Francisco, California + 20 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00759018" }, { "nct_id": "NCT00826046", "title": "Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD)", "overall_status": "NO_LONGER_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Graft-Versus-Host Disease" ], "interventions": [ { "name": "Prochymal®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2020-03-09", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 3, "location_summary": "Beech Grove, Indiana • Boston, Massachusetts • New York, New York", "locations": [ { "city": "Beech Grove", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00826046" }, { "nct_id": "NCT00136903", "title": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft Vs Host Disease" ], "interventions": [ { "name": "Prochymal® - 2 Million cells/kg", "type": "DRUG" }, { "name": "Prochymal®- 8 Million cells/kg", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 32, "start_date": "2005-04-27", "completion_date": "2008-07-14", "has_results": false, "last_update_posted_date": "2022-01-31", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 9, "location_summary": "Indianapolis, Indiana • Kansas City, Missouri • Hackensack, New Jersey + 6 more", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "Buffalo", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00136903" }, { "nct_id": "NCT00482092", "title": "Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Prochymal®", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 330, "start_date": "2007-09-17", "completion_date": "2014-09-15", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 47, "location_summary": "Los Angeles, California • San Francisco, California • Wheat Ridge, Colorado + 38 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00482092" }, { "nct_id": "NCT00877903", "title": "Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myocardial Infarction" ], "interventions": [ { "name": "Prochymal®", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "21 Years to 85 Years" }, "enrollment_count": 220, "start_date": "2009-03-30", "completion_date": "2016-03-14", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-03T03:04:08.464Z", "location_count": 32, "location_summary": "Gilbert, Arizona • Tucson, Arizona • Sacramento, California + 29 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00877903" } ] }